2-amino-5-phosphonovalerate has been researched along with cgp 39551 in 70 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 57 (81.43) | 18.2507 |
2000's | 9 (12.86) | 29.6817 |
2010's | 4 (5.71) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Kretschmer, BD; Schmidt, WJ; Volz, L; Volz, TL; Zadow, B | 1 |
Baudry, M; Maren, S; Thompson, RF | 1 |
Bradford, HF; Cotterell, KL; Croucher, MJ | 2 |
Bischoff, C; Tiedtke, PI | 1 |
Barnabei, O; Contestabile, A; Migani, P; Virgili, M | 1 |
Bubser, M; Keseberg, U; Notz, PK; Schmidt, WJ | 1 |
Hönack, D; Löscher, W | 1 |
Liljequist, S | 1 |
Fassbender, CP; Hönack, D; Löscher, W | 1 |
Asikainen, A; Freund, TF; Gulyas, A; Lahtinen, H; Partanen, J; Riekkinen, P; Sirviö, J; Ylinen, A | 1 |
Baud, J; Baumann, P; Bittiger, H; Fagg, GE; Olpe, HR; Portet, C; Pozza, MF; Schmutz, M; Steinmann, M; Thedinga, K | 1 |
Brugger, F; Fagg, GE; Olpe, HR; Pozza, MF | 1 |
Allgeier, H; Fagg, GE; Heckendorn, R; Jeker, A; Klebs, K; Olpe, HR; Portet, C; Schmutz, M; van Riezen, H; Vassout, A | 1 |
Allgeier, H; Angst, C; Bittiger, H; Brundish, D; Fagg, GE; Heckendorn, R; Olpe, HR; Pozza, MF; Schmutz, M; van Riezen, H | 1 |
Fagg, GE; Massieu, L; McVey, M; Thedinga, KH | 1 |
Mennini, T; Miari, A; Presti, ML; Rizzi, M; Samanin, R; Vezzani, A | 1 |
Little, HJ; Rabbani, M; Wright, EJ | 1 |
Ammendola, D; De Sarro, A; De Sarro, G; Nava, F | 1 |
Hartikainen, T; Koivisto, E; Pitkänen, M; Riekkinen, PJ; Sirviö, J; Sivenius, J; Ylinen, A | 1 |
Barnabei, O; Contestabile, A; Virgili, M | 1 |
Little, HJ; Ripley, TL | 2 |
Millan, MJ; Seguin, L | 1 |
Contestabile, A; Facchinetti, F; Virgili, M | 1 |
Ciani, E; Contestabile, A; Facchinetti, F; Virgili, M | 1 |
Contestabile, A; Dall'Olio, R; Facchinetti, F; Gandolfi, O | 1 |
Jessa, M; Nazar, M; Palejko, W; Plaznik, A | 1 |
Halsey, MJ; Henley, M; Maclean, CJ; Meldrum, BS; Pearce, PC; Pearson, J; Ward, EM | 1 |
Hyvönen, M; Lahtinen, H; Miettinen, R; Riekkinen, PJ; Sirviö, J; Ylinen, A | 1 |
Annies, R; Hönack, D; Löscher, W | 1 |
Hönack, D; Löscher, W; Rundfeldt, C | 1 |
Czechowska, G; Czuczwar, SJ; Dziki, M; Kleinrok, Z; Pietrasiewicz, T; Turski, WA | 2 |
De Witte, P; Deuceuninck, D; Lamblin, F | 1 |
Butterworth, AR; Little, HJ; Rabbani, M; Wright, J; Zhou, Q | 1 |
Ciani, E; Contestabile, A; Guarnieri, T | 1 |
Ciani, E; Contestabile, A; Dall'Olio, R; Facchinetti, F; Sparapani, M; Virgili, M | 1 |
Fratelli, M; Rizzi, M; Sparvoli, S; Vezzani, A; Zinetti, M | 1 |
Hatipoğlu, I; Koyuncuoğlu, H; Sarica, O | 1 |
Ciani, E; Contestabile, A; Facchinetti, F; Sparapani, M; Virgili, M | 1 |
Ciani, E; Contestabile, A; Dall'Olio, R; Facchinetti, F; Fonnum, F; Virgili, M | 1 |
Maj, J; Rogóz, Z; Skuza, G | 1 |
Foy, MR; Kim, JJ; Thompson, RF | 1 |
Gall, CM; Guthrie, KM; Sullivan, RM; Wilson, DA | 1 |
Ammendola, D; De Sarro, A; De Sarro, G; Patel, S | 1 |
Mares, P; Vachová, D; Velísek, L | 1 |
Ciani, E; Contestabile, A; Paulsen, RE; Rizzi, S | 1 |
Danysz, W; Frankiewicz, T; Parsons, CG; Zajaczkowski, W | 1 |
Cabello, P; Contreras, E; Germany, A; González, P; Norris, B | 1 |
Ciani, E; Contestabile, A; Dall'Olio, R; Gandolfi, O; Sparapani, M | 1 |
Dunworth, SJ; Stephens, DN | 1 |
Contestabile, A; Dall'Olio, R; Facchinetti, F; Gandolfi, O; Lucchi, R; Sparapani, M; Tregnago, M; Virgili, M | 1 |
D'Hooge, R; De Deyn, PP; Hiramatsu, M; Mori, A; Raes, A; Van Bogaert, PP | 1 |
D'Hooge, R; De Deyn, PP; Raes, A; Van Bogaert, PP; Van de Vijver, G | 1 |
Bäckström, P; Hyytiä, P; Liljequist, S | 1 |
Danysz, W; Karcz-Kubicha, M; Wedzony, K; Zajaczkowski, W | 1 |
Contestabile, A; Monti, B | 1 |
Marcus, MM; Mathé, JM; Nomikos, GG; Svensson, TH | 1 |
Dunworth, SJ; Ripley, TL; Stephens, DN | 1 |
Contestabile, A; Marri, L; Monti, B | 1 |
Cebere, A; Cebers, G; Kosowski, AR; Liljequist, S; Swanhagen, AC | 1 |
Grillner, P; Jardemark, K; Mameli-Engvall, M; Rawal, N; Schilström, B; Svensson, TH | 1 |
Kosowski, AR; Liljequist, S | 1 |
Delgado-García, JM; Gruart, A; Muñoz, MD | 1 |
Ivanov, VB; Schilström, B; Svensson, TH; Wiker, C | 1 |
Bevins, RA; Murray, JE; Polewan, RJ; Walker, AW | 1 |
Czuczwar, M; Kiś, J; Nieoczym, D; Rejdak, K; Turski, WA; Wlaź, P | 1 |
Al-Mohanna, FA; Andres, B; Collison, KS; Inglis, A; Mata, P; Shibin, S; Thiam, J; Ubungen, R | 1 |
Al-Mohanna, FA; Andres, B; Collison, KS; Inglis, A; Mata, P; Saleh, S; Shibin, S; Thiam, J; Ubungen, R | 1 |
1 review(s) available for 2-amino-5-phosphonovalerate and cgp 39551
Article | Year |
---|---|
CGP 37849 and CGP 39551: novel competitive N-methyl-D-aspartate receptor antagonists with potent oral anticonvulsant activity.
Topics: 2-Amino-5-phosphonovalerate; Administration, Oral; Animals; Anticonvulsants; Binding, Competitive; Kinetics; Rats; Receptors, N-Methyl-D-Aspartate | 1990 |
69 other study(ies) available for 2-amino-5-phosphonovalerate and cgp 39551
Article | Year |
---|---|
The contribution of the different binding sites of the N-methyl-D-aspartate (NMDA) receptor to the expression of behavior.
Topics: 2-Amino-5-phosphonovalerate; Animals; Behavior, Animal; Binding Sites; Catalepsy; Cycloserine; Dizocilpine Maleate; Haloperidol; Male; Motor Activity; Rats; Rats, Inbred Strains; Receptors, N-Methyl-D-Aspartate | 1992 |
Effects of the novel NMDA receptor antagonist, CGP 39551, on field potentials and the induction and expression of LTP in the dentate gyrus in vivo.
Topics: 2-Amino-5-phosphonovalerate; Anesthesia; Animals; Electrophysiology; Evoked Potentials; Hippocampus; Male; Neuronal Plasticity; Rats; Receptors, N-Methyl-D-Aspartate; Synaptic Transmission | 1992 |
Weak anticonvulsant activity of CGP 37849 and CGP 39551 against kindled seizures following systemic administration.
Topics: 2-Amino-5-phosphonovalerate; Animals; Anticonvulsants; Injections, Intraperitoneal; Injections, Intravenous; Kindling, Neurologic; Male; Motor Activity; Rats; Rats, Inbred Strains; Receptors, N-Methyl-D-Aspartate; Seizures | 1992 |
Competitive and non-competitive NMDA receptor antagonists in spatial learning tasks.
Topics: 2-Amino-5-phosphonovalerate; Animals; Behavior, Animal; Dizocilpine Maleate; Learning; Male; Memory; Motor Activity; Orientation; Rats; Rats, Inbred Strains; Receptors, N-Methyl-D-Aspartate | 1992 |
Competitive NMDA receptor antagonists raise electrically kindled generalized seizure thresholds.
Topics: 2-Amino-5-phosphonovalerate; Amygdala; Animals; Anticonvulsants; Binding, Competitive; Electric Stimulation; Kindling, Neurologic; Male; Rats; Rats, Inbred Strains; Receptors, N-Methyl-D-Aspartate; Seizures | 1992 |
Protection from kainic acid neuropathological syndrome by NMDA receptor antagonists: effect of MK-801 and CGP 39551 on neurotransmitter and glial markers.
Topics: 2-Amino-5-phosphonovalerate; Animals; Dizocilpine Maleate; Epilepsy; Kainic Acid; Male; Neuroglia; Neurotransmitter Agents; Rats; Rats, Inbred Strains; Receptors, N-Methyl-D-Aspartate; Syndrome | 1992 |
Differential behavioural and neurochemical effects of competitive and non-competitive NMDA receptor antagonists in rats.
Topics: 2-Amino-5-phosphonovalerate; Animals; Brain Chemistry; Chromatography, High Pressure Liquid; Dizocilpine Maleate; Dopamine; Male; Memantine; Motor Activity; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate | 1992 |
Anticonvulsant and behavioral effects of two novel competitive N-methyl-D-aspartic acid receptor antagonists, CGP 37849 and CGP 39551, in the kindling model of epilepsy. Comparison with MK-801 and carbamazepine.
Topics: 2-Amino-5-phosphonovalerate; Animals; Anticonvulsants; Ataxia; Behavior, Animal; Carbamazepine; Dizocilpine Maleate; Female; Kindling, Neurologic; Motor Activity; N-Methylaspartate; Phencyclidine; Rats; Rats, Inbred Strains; Receptors, N-Methyl-D-Aspartate | 1991 |
The competitive NMDA receptor antagonist, CGP 39551, inhibits ethanol withdrawal seizures.
Topics: 2-Amino-5-phosphonovalerate; Animals; Diet; Dizocilpine Maleate; Ethanol; Hippocampus; Mice; Mice, Inbred C57BL; Receptors, N-Methyl-D-Aspartate; Seizures; Substance Withdrawal Syndrome | 1991 |
Regional alterations in brain amino acids after administration of the N-methyl-D-aspartate receptor antagonists MK-801 and CGP 39551 in rats.
Topics: 2-Amino-5-phosphonovalerate; Amino Acids; Animals; Binding, Competitive; Brain Chemistry; Brain Mapping; Dizocilpine Maleate; Female; N-Methylaspartate; Neurotransmitter Agents; Rats; Rats, Inbred Strains; Receptors, N-Methyl-D-Aspartate | 1991 |
Behavioural, electrophysiological and histopathological changes following sustained stimulation of the perforant pathway input to the hippocampus: effect of the NMDA receptor antagonist, CGP 39551.
Topics: 2-Amino-5-phosphonovalerate; Animals; Electroencephalography; Hippocampus; Learning; Male; Memory; Neurons; Rats; Rats, Inbred Strains; Receptors, N-Methyl-D-Aspartate | 1991 |
CGP 37849 and CGP 39551: novel and potent competitive N-methyl-D-aspartate receptor antagonists with oral activity.
Topics: 2-Amino-5-phosphonovalerate; Animals; Anticonvulsants; Binding, Competitive; Electrophysiology; Electroshock; Glutamates; Hippocampus; In Vitro Techniques; Kinetics; Male; Neurotransmitter Agents; Radioligand Assay; Rats; Rats, Inbred Strains; Receptors, N-Methyl-D-Aspartate; Receptors, Neurotransmitter; Sodium; Valine | 1990 |
Electrophysiological characterization of a novel potent and orally active NMDA receptor antagonist: CGP 37849 and its ethylester CGP 39551.
Topics: 2-Amino-5-phosphonovalerate; Animals; Behavior, Animal; Electrophysiology; Hippocampus; Iontophoresis; Male; Oxadiazoles; Piperazines; Quisqualic Acid; Rats; Rats, Inbred Strains; Receptors, N-Methyl-D-Aspartate; Receptors, Neurotransmitter; Spinal Cord; Substantia Nigra; Valine | 1990 |
The competitive NMDA receptor antagonists CGP 37849 and CGP 39551 are potent, orally-active anticonvulsants in rodents.
Topics: 2-Amino-5-phosphonovalerate; Animals; Anticonvulsants; Electroshock; Kindling, Neurologic; Male; Mice; Mice, Inbred Strains; Pentylenetetrazole; Postural Balance; Rats; Rats, Inbred Strains; Receptors, N-Methyl-D-Aspartate; Receptors, Neurotransmitter | 1990 |
A comparative analysis of the neuroprotective properties of competitive and uncompetitive N-methyl-D-aspartate receptor antagonists in vivo: implications for the process of excitotoxic degeneration and its therapy.
Topics: 2-Amino-5-phosphonovalerate; Acetylcholine; alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Animals; Binding, Competitive; Biomarkers; Cell Death; Choline O-Acetyltransferase; Corpus Striatum; Dizocilpine Maleate; Drug Administration Schedule; gamma-Aminobutyric Acid; Glutamate Decarboxylase; Injections; Injections, Intraperitoneal; Kainic Acid; Male; Nerve Degeneration; Nerve Tissue Proteins; Neurons; Neurotoxins; Pipecolic Acids; Piperazines; Quinolinic Acid; Rats; Receptors, N-Methyl-D-Aspartate | 1993 |
Adaptive changes in the NMDA receptor complex in rat hippocampus after chronic treatment with CGP 39551.
Topics: 2-Amino-5-phosphonovalerate; Animals; Autoradiography; Dizocilpine Maleate; Glutamic Acid; Hippocampus; Kynurenic Acid; Male; Norepinephrine; Phencyclidine; Quinolinic Acid; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate | 1994 |
Tolerance to competitive NMDA antagonists, but no crosstolerance with barbiturates.
Topics: 2-Amino-5-phosphonovalerate; Animals; Ataxia; Behavior, Animal; Dizocilpine Maleate; Drug Tolerance; Hypnotics and Sedatives; Male; Mice; Motor Activity; N-Methylaspartate; Pyrrolidinones; Receptors, N-Methyl-D-Aspartate; Seizures; Substance Withdrawal Syndrome | 1995 |
Effects of some excitatory amino acid antagonists on imipenem-induced seizures in DBA/2 mice.
Topics: 2-Amino-5-phosphonovalerate; 6-Cyano-7-nitroquinoxaline-2,3-dione; Amino Acids; Animals; Anticonvulsants; Dizocilpine Maleate; Excitatory Amino Acids; Glutamine; Imipenem; Kynurenic Acid; Mice; Mice, Inbred DBA; Muscimol; Piperazines; Piperidines; Quinoxalines; Seizures | 1995 |
The effects of NMDA receptor antagonists at anticonvulsive doses on the performance of rats in the water maze task.
Topics: 2-Amino-5-phosphonovalerate; Analysis of Variance; Animals; Anticonvulsants; Behavior, Animal; Binding, Competitive; Dizocilpine Maleate; Electroshock; Learning; Male; Memory; Rats; Rats, Wistar; Receptors, N-Methyl-D-Aspartate; Swimming | 1995 |
Simultaneous blockade of non-NMDA ionotropic receptors and NMDA receptor-associated ionophore partially protects hippocampal slices from protein synthesis impairment due to simulated ischemia.
Topics: 2-Amino-5-phosphonovalerate; Amino Acids; Animals; Brain Ischemia; Dizocilpine Maleate; Excitatory Amino Acid Antagonists; Glucose; Hippocampus; In Vitro Techniques; Ionophores; Leucine; Male; Nerve Tissue Proteins; Quinoxalines; Rats; Rats, Wistar; Receptors, AMPA; Receptors, N-Methyl-D-Aspartate | 1995 |
Effects on ethanol withdrawal hyperexcitability of chronic treatment with a competitive N-methyl-D-aspartate receptor antagonist.
Topics: 2-Amino-5-phosphonovalerate; Animals; Drug Administration Schedule; Ethanol; Handling, Psychological; Male; Mice; Mice, Inbred Strains; Receptors, N-Methyl-D-Aspartate; Seizures; Substance Withdrawal Syndrome; Time Factors | 1995 |
Chemically-diverse ligands at the glycine B site coupled to N-methyl-D-aspartate (NMDA) receptors selectively block the late phase of formalin-induced pain in mice.
Topics: 2-Amino-5-phosphonovalerate; Acetates; Acetic Acid; Animals; Anticonvulsants; Cycloserine; Dizocilpine Maleate; Dose-Response Relationship, Drug; Formaldehyde; Indoles; Ligands; Male; Mice; Mice, Inbred Strains; Motor Activity; Pain; Propionates; Pyrrolidinones; Quinolones; Receptors, Glycine; Receptors, N-Methyl-D-Aspartate | 1994 |
Chronic neonatal NMDA blockade results in long-term cholinergic increase in the rat spinal cord.
Topics: 2-Amino-5-phosphonovalerate; Acetylcholine; Analysis of Variance; Animals; Animals, Newborn; Biomarkers; Neurons; Rats; Rats, Wistar; Receptors, N-Methyl-D-Aspartate; Spinal Cord; Time Factors | 1994 |
Decreased excitotoxic sensitivity in the olfactory cortex of adult rats after neonatal NMDA blockade.
Topics: 2-Amino-5-phosphonovalerate; Analysis of Variance; Animals; Animals, Newborn; Enzyme Induction; Hippocampus; Kainic Acid; Nerve Degeneration; Olfactory Bulb; Ornithine Decarboxylase; Rats; Rats, Wistar; Receptors, N-Methyl-D-Aspartate | 1994 |
Chronic neonatal blockade of N-methyl-D-aspartate receptor by CGP 39551 increases dopaminergic function in adult rat.
Topics: 2-Amino-5-phosphonovalerate; Animals; Animals, Newborn; Apomorphine; Behavior, Animal; Corpus Striatum; Dopamine; Dopamine Agonists; Ergolines; Motor Activity; Quinpirole; Rats; Rats, Wistar; Receptors, Dopamine; Receptors, N-Methyl-D-Aspartate; Spiperone; Stereotyped Behavior; Time Factors | 1994 |
Effects of antagonists at the NMDA receptor complex in two models of anxiety.
Topics: 2-Amino-5-phosphonovalerate; Animals; Anxiety; Behavior, Animal; Conflict, Psychological; Diazepam; Dizocilpine Maleate; Drinking; Electroshock; Exploratory Behavior; Injections, Intraventricular; Kynurenic Acid; Male; Motor Activity; Rats; Rats, Wistar; Receptors, Glycine; Receptors, N-Methyl-D-Aspartate | 1994 |
The orally active NMDA receptor antagonist CGP 39551 ameliorates the high pressure neurological syndrome in Papio anubis.
Topics: 2-Amino-5-phosphonovalerate; Administration, Oral; Animals; Anticonvulsants; Electroencephalography; Female; High Pressure Neurological Syndrome; Male; Papio; Receptors, N-Methyl-D-Aspartate; Seizures; Tremor | 1993 |
Preservation of hippocampal NMDA receptors may be crucial for spatial learning after epileptic seizures in rats.
Topics: 2-Amino-5-phosphonovalerate; Animals; Cognition Disorders; Electric Stimulation; Epilepsy; Glutamates; Glutamic Acid; Hippocampus; Learning; Male; N-Methylaspartate; Neurons; Rats; Rats, Wistar; Receptors, N-Methyl-D-Aspartate; Somatostatin; Space Perception | 1993 |
Comparison of competitive and uncompetitive NMDA receptor antagonists with regard to monoaminergic neuronal activity and behavioural effects in rats.
Topics: 2-Amino-5-phosphonovalerate; Animals; Binding, Competitive; Biogenic Monoamines; Brain; Dizocilpine Maleate; Female; Motor Activity; Neurons; Rats; Rats, Wistar; Receptors, N-Methyl-D-Aspartate; Stereotyped Behavior | 1993 |
Low doses of NMDA receptor antagonists synergistically increase the anticonvulsant effect of the AMPA receptor antagonist NBQX in the kindling model of epilepsy.
Topics: 2-Amino-5-phosphonovalerate; Amygdala; Animals; Anticonvulsants; Dizocilpine Maleate; Dose-Response Relationship, Drug; Drug Synergism; Electric Stimulation; Epilepsies, Partial; Female; Kindling, Neurologic; Motor Activity; Quinoxalines; Rats; Rats, Wistar; Receptors, AMPA; Receptors, N-Methyl-D-Aspartate; Stereotyped Behavior | 1993 |
Competitive NMDA receptor antagonists enhance the antielectroshock activity of various antiepileptics.
Topics: 2-Amino-5-phosphonovalerate; Animals; Anticonvulsants; Avoidance Learning; Behavior, Animal; Carbamazepine; Drug Synergism; Electroshock; Male; Memory; Mice; Motor Activity; Phenobarbital; Phenytoin; Receptors, N-Methyl-D-Aspartate; Seizures | 1993 |
Modulation of alcohol preference by NMDA antagonists in male rats.
Topics: 2-Amino-5-phosphonovalerate; Animals; Behavior, Animal; Brain; Capillary Permeability; Choice Behavior; Ethanol; Magnesium; Male; Motor Activity; N-Methylaspartate; Rats; Rats, Wistar; Receptors, N-Methyl-D-Aspartate; Substance Withdrawal Syndrome | 1993 |
Possible involvement of NMDA receptor-mediated transmission in barbiturate physical dependence.
Topics: 2-Amino-5-phosphonovalerate; Animals; Barbital; Bicuculline; Cerebral Cortex; Dizocilpine Maleate; Hippocampus; Male; Mice; Motor Activity; N-Methylaspartate; Receptors, N-Methyl-D-Aspartate; Seizures; Substance Withdrawal Syndrome | 1994 |
Fos protein induction, neuropathology, and pharmacological protection after excitotoxic brain insult.
Topics: 2-Amino-5-phosphonovalerate; Animals; Brain; Injections; Kainic Acid; Male; N-Methylaspartate; Neurotoxins; Proto-Oncogene Proteins c-fos; Rats; Rats, Wistar; Time Factors | 1994 |
Long-lasting effects of chronic neonatal blockade of N-methyl-D-aspartate receptor through the competitive antagonist CGP 39551 in rats.
Topics: 2-Amino-5-phosphonovalerate; 2',3'-Cyclic-Nucleotide Phosphodiesterases; Aging; Animals; Animals, Newborn; Aspartic Acid; Benzamides; Benzazepines; Choline O-Acetyltransferase; Corpus Striatum; Dizocilpine Maleate; Dopamine; Dopamine D2 Receptor Antagonists; Dose-Response Relationship, Drug; Drug Administration Schedule; Glutamate Decarboxylase; Glutamate-Ammonia Ligase; Motor Activity; Nutrition Disorders; Rats; Rats, Wistar; Receptors, Dopamine D1; Receptors, N-Methyl-D-Aspartate | 1994 |
Changes in the ADP-ribosylation status of some hippocampal proteins are linked to kindling progression.
Topics: 2-Amino-5-phosphonovalerate; Adenosine Diphosphate Ribose; Animals; Arginine; Autoradiography; Electrophoresis, Polyacrylamide Gel; Hemoglobins; Hippocampus; Injections, Intraventricular; Kindling, Neurologic; Male; Nerve Tissue Proteins; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitroprusside; Protein Processing, Post-Translational; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate; Receptors, Purinergic P2 | 1994 |
Morphine physical dependence intensification by hypoglycemia: NMDA receptor involvement.
Topics: 2-Amino-5-phosphonovalerate; Animals; Behavior, Animal; Brain; Dizocilpine Maleate; Hypoglycemia; Insulin; Male; Morphine Dependence; Rats; Rats, Wistar; Receptors, N-Methyl-D-Aspartate; Substance Withdrawal Syndrome | 1994 |
Chronic neonatal blockade of NMDA receptor does not affect developmental polyamine metabolism but results in altered response to the excitotoxic induction of ornithine decarboxylase.
Topics: 2-Amino-5-phosphonovalerate; Aging; Animals; Animals, Newborn; Brain; Cerebellum; Cerebral Cortex; Enzyme Induction; Hippocampus; Ornithine Decarboxylase; Polyamines; Putrescine; Rats; Rats, Wistar; Receptors, N-Methyl-D-Aspartate; Reference Values; Spermidine; Spermine; Telencephalon | 1994 |
Competitive antagonists of NMDA receptors, CGP 37849 and CGP 39551, enhance the anticonvulsant activity of valproate against electroconvulsions in mice.
Topics: 2-Amino-5-phosphonovalerate; Animals; Anticonvulsants; Behavior, Animal; Dose-Response Relationship, Drug; Drug Synergism; Electroshock; Male; Mice; Receptors, N-Methyl-D-Aspartate; Seizures; Valproic Acid | 1993 |
Structural, neurochemical and behavioural consequences of neonatal blockade of NMDA receptor through chronic treatment with CGP 39551 or MK-801.
Topics: 2-Amino-5-phosphonovalerate; Animals; Animals, Newborn; Behavior, Animal; Body Weight; Brain; Brain Chemistry; Choline O-Acetyltransferase; Dizocilpine Maleate; Female; Motor Activity; Pregnancy; Rats; Rats, Wistar; Receptors, N-Methyl-D-Aspartate | 1993 |
Some central effects of CGP 37849 and CGP 39551, the competitive NMDA receptor antagonists: potential antiparkinsonian activity.
Topics: 2-Amino-5-phosphonovalerate; alpha-Methyltyrosine; Animals; Antiparkinson Agents; Antipsychotic Agents; Biogenic Monoamines; Catalepsy; Central Nervous System Agents; Clonidine; Levodopa; Male; Methyltyrosines; Motor Activity; Rats; Rats, Wistar; Receptors, N-Methyl-D-Aspartate; Reserpine; Tyrosine 3-Monooxygenase | 1993 |
Ethanol withdrawal hyperexcitability in vitro is selectively decreased by a competitive NMDA receptor antagonist.
Topics: 2-Amino-5-phosphonovalerate; Animals; Dose-Response Relationship, Drug; Ethanol; Excitatory Amino Acid Antagonists; Hippocampus; In Vitro Techniques; Male; Mice; Mice, Inbred C57BL; Receptors, N-Methyl-D-Aspartate; Substance Withdrawal Syndrome; Time Factors | 1995 |
Behavioral stress modifies hippocampal plasticity through N-methyl-D-aspartate receptor activation.
Topics: 2-Amino-5-phosphonovalerate; Animals; Behavior, Animal; Excitatory Amino Acid Antagonists; Hippocampus; Humans; Infant, Newborn; Learning; Long-Term Potentiation; Male; Memory; Neuronal Plasticity; Rats; Receptors, N-Methyl-D-Aspartate; Stress, Physiological | 1996 |
NMDA-receptor modulation of lateral inhibition and c-fos expression in olfactory bulb.
Topics: 2-Amino-5-phosphonovalerate; Analysis of Variance; Animals; Dizocilpine Maleate; Evoked Potentials; Excitatory Amino Acid Antagonists; Ketamine; Male; Neural Inhibition; Olfactory Bulb; Proto-Oncogene Proteins c-fos; Rats; Rats, Wistar; Receptors, N-Methyl-D-Aspartate; RNA, Messenger | 1996 |
Lack of development of tolerance to anticonvulsant effects of two excitatory amino acid antagonists, CGP [corrected] 37849 and CGP 39551 in genetically epilepsy-prone rats.
Topics: 2-Amino-5-phosphonovalerate; Animals; Anticonvulsants; Drug Administration Schedule; Drug Tolerance; Epilepsy; Excitatory Amino Acid Antagonists; Genetic Predisposition to Disease; Male; Motor Activity; Rats; Rats, Sprague-Dawley | 1996 |
Excitatory amino acid antagonists and pentylenetetrazol-induced seizures during ontogenesis. IV. Effects of CGP 39551.
Topics: 2-Amino-5-phosphonovalerate; Animals; Anticonvulsants; Convulsants; Drug Evaluation, Preclinical; Epilepsy, Tonic-Clonic; Excitatory Amino Acid Antagonists; Male; Pentylenetetrazole; Rats; Rats, Wistar | 1997 |
Chronic pre-explant blockade of the NMDA receptor affects survival of cerebellar granule cells explanted in vitro.
Topics: 2-Amino-5-phosphonovalerate; Animals; Animals, Newborn; Apoptosis; Cell Survival; Cellular Senescence; Cerebellum; Dizocilpine Maleate; Excitatory Amino Acid Antagonists; Glutamic Acid; Neurons; Neuroprotective Agents; Potassium; Rats; Rats, Wistar; Receptors, N-Methyl-D-Aspartate | 1997 |
Uncompetitive NMDA receptor antagonists attenuate NMDA-induced impairment of passive avoidance learning and LTP.
Topics: 2-Amino-5-phosphonovalerate; Animals; Avoidance Learning; Dizocilpine Maleate; Dose-Response Relationship, Drug; Excitatory Amino Acid Antagonists; Long-Term Potentiation; Male; Memantine; N-Methylaspartate; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate | 1997 |
Decrease of tolerance to, and physical dependence on morphine by, glutamate receptor antagonists.
Topics: 2-Amino-5-phosphonovalerate; Animals; Dizocilpine Maleate; Drug Tolerance; Excitatory Amino Acid Antagonists; Ketamine; Male; Mice; Morphine; Morphine Dependence; Pain Measurement; Substance Withdrawal Syndrome | 1997 |
Neurotoxicity of polyamines and pharmacological neuroprotection in cultures of rat cerebellar granule cells.
Topics: 2-Amino-5-phosphonovalerate; Animals; Apoptosis; Aspartic Acid; Butylated Hydroxytoluene; Cells, Cultured; Cerebellar Cortex; Dizocilpine Maleate; Enzyme Inhibitors; Excitatory Amino Acid Antagonists; Female; Free Radical Scavengers; Glutamic Acid; L-Lactate Dehydrogenase; Male; Nerve Tissue Proteins; Neurons; Neuroprotective Agents; Nitric Oxide Synthase; Nitroarginine; Piperidines; Putrescine; Quinoxalines; Rats; Rats, Wistar; Receptors, N-Methyl-D-Aspartate; Spermidine; Spermine; Vitamin E | 1997 |
Sensitisation to repeated withdrawal, in mice treated chronically with diazepam, is blocked by an NMDA receptor antagonist.
Topics: 2-Amino-5-phosphonovalerate; Animals; Anti-Anxiety Agents; Convulsants; Diazepam; Excitatory Amino Acid Antagonists; Glutamic Acid; Male; Mice; Mice, Inbred C57BL; Pentylenetetrazole; Receptors, N-Methyl-D-Aspartate; Seizures; Substance Withdrawal Syndrome; Synaptic Transmission | 1998 |
Neuronal nitric oxide synthase is permanently decreased in the cerebellum of rats subjected to chronic neonatal blockade of N-methyl-D-aspartate receptors.
Topics: 2-Amino-5-phosphonovalerate; Animals; Animals, Newborn; Benzamides; Body Weight; Cerebellum; Depression, Chemical; Dopamine Antagonists; Excitatory Amino Acid Antagonists; Hyperkinesis; Immunohistochemistry; Nitric Oxide Synthase; Nitric Oxide Synthase Type I; Organ Size; Rats; Rats, Wistar; Receptors, N-Methyl-D-Aspartate; Time | 1998 |
Effects of the competitive N-methyl-D-aspartate antagonist CGP 37849 and its ethylester CGP 39551 on N-methyl-D-aspartate-evoked whole-cell currents in cultured spinal neurones and on vestibular stimulation-induced seizures in EL mice.
Topics: 2-Amino-5-phosphonovalerate; Animals; Anticonvulsants; Avoidance Learning; Cells, Cultured; Electric Stimulation; Excitatory Amino Acid Antagonists; Male; Mice; Mice, Inbred Strains; N-Methylaspartate; Neurons; Patch-Clamp Techniques; Postural Balance; Receptors, N-Methyl-D-Aspartate; Seizures; Spinal Cord; Vestibule, Labyrinth | 1998 |
Effects of competitive NMDA receptor antagonists on excitatory amino acid-evoked currents in mouse spinal cord neurones.
Topics: 2-Amino-5-phosphonovalerate; 6-Cyano-7-nitroquinoxaline-2,3-dione; alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Animals; Aspartic Acid; Binding, Competitive; Dose-Response Relationship, Drug; Excitatory Amino Acid Agonists; Excitatory Amino Acid Antagonists; Excitatory Amino Acids; Glutamic Acid; Kainic Acid; Membrane Potentials; Mice; N-Methylaspartate; Neurons; Patch-Clamp Techniques; Receptors, N-Methyl-D-Aspartate; Spinal Cord | 1999 |
Site-specific NMDA receptor antagonists produce differential effects on cocaine self-administration in rats.
Topics: 2-Amino-5-phosphonovalerate; Animals; Cocaine; Dizocilpine Maleate; Excitatory Amino Acid Antagonists; Male; Memantine; Rats; Rats, Wistar; Receptors, N-Methyl-D-Aspartate; Self Administration | 1999 |
NMDA receptor antagonists acting at the glycineB site in rat models for antipsychotic-like activity.
Topics: 2-Amino-5-phosphonovalerate; Amphetamine; Animals; Antimetabolites; Antipsychotic Agents; Binding Sites; Cycloleucine; Cycloserine; Disease Models, Animal; Dopamine Agents; Drug Synergism; Excitatory Amino Acid Antagonists; Glycine; Hallucinogens; Locomotion; Male; Phencyclidine; Phthalazines; Protein Structure, Tertiary; Psychotic Disorders; Pyrrolidinones; Quinolones; Rats; Rats, Sprague-Dawley; Receptors, Glycine; Receptors, N-Methyl-D-Aspartate; Reflex, Startle | 1999 |
Blockade of the NMDA receptor increases developmental apoptotic elimination of granule neurons and activates caspases in the rat cerebellum.
Topics: 2-Amino-5-phosphonovalerate; Animals; Apoptosis; Caspase 1; Caspase 3; Caspases; Cell Differentiation; Cerebellum; DNA Fragmentation; Excitatory Amino Acid Antagonists; In Situ Nick-End Labeling; Neurons; Ornithine Decarboxylase; Rats; Rats, Wistar; Receptors, N-Methyl-D-Aspartate | 2000 |
Effects of competitive and non-competitive NMDA receptor antagonists on dopamine output in the shell and core subdivisions of the nucleus accumbens.
Topics: 2-Amino-5-phosphonovalerate; Animals; Binding, Competitive; Dizocilpine Maleate; Dopamine; Excitatory Amino Acid Antagonists; Extracellular Space; Male; Nucleus Accumbens; Phencyclidine; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate; Time Factors | 2001 |
Effect of CGP39551 administration on the kindling of ethanol-withdrawal seizures.
Topics: 2-Amino-5-phosphonovalerate; Alcohol Withdrawal Seizures; Animals; Dose-Response Relationship, Drug; Drug Synergism; Ethanol; Kindling, Neurologic; Male; Mice; Mice, Inbred C57BL; Motor Activity | 2002 |
NMDA receptor-dependent CREB activation in survival of cerebellar granule cells during in vivo and in vitro development.
Topics: 2-Amino-5-phosphonovalerate; Animals; Animals, Newborn; Apoptosis; Cell Differentiation; Cell Survival; Cells, Cultured; Cerebellar Cortex; Colforsin; Cyclic AMP Response Element-Binding Protein; Dizocilpine Maleate; Excitatory Amino Acid Antagonists; Immunohistochemistry; N-Methylaspartate; Neurons; Rats; Rats, Wistar; Receptors, N-Methyl-D-Aspartate; Synaptic Transmission | 2002 |
Nicotine-induced dopamine release in the nucleus accumbens is inhibited by the novel AMPA antagonist ZK200775 and the NMDA antagonist CGP39551.
Topics: 2-Amino-5-phosphonovalerate; Animals; Cell Survival; Cells, Cultured; Cerebellum; Dopamine; Male; Microdialysis; Motor Activity; Nicotine; Nucleus Accumbens; Organophosphonates; Quinoxalines; Radioligand Assay; Rats; Rats, Sprague-Dawley; Rats, Wistar; Receptors, AMPA; Receptors, N-Methyl-D-Aspartate; Receptors, Nicotinic; Time Factors | 2004 |
Nitric oxide is involved in nicotine-induced burst firing of rat ventral tegmental area dopamine neurons.
Topics: 2-Amino-5-phosphonovalerate; Animals; Dopamine; Electrophysiology; Enzyme Inhibitors; Excitatory Amino Acid Antagonists; Ganglionic Stimulants; Male; Membrane Potentials; Neurons; NG-Nitroarginine Methyl Ester; Nicotine; Nitric Oxide; Organ Culture Techniques; Patch-Clamp Techniques; Rats; Rats, Sprague-Dawley; Ventral Tegmental Area | 2004 |
The NR2B-selective N-methyl-D-aspartate receptor antagonist Ro 25-6981 [(+/-)-(R*,S*)-alpha-(4-hydroxyphenyl)-beta-methyl-4-(phenylmethyl)-1-piperidine propanol] potentiates the effect of nicotine on locomotor activity and dopamine release in the nucleus
Topics: 2-Amino-5-phosphonovalerate; Animals; Dizocilpine Maleate; Dopamine; Drug Synergism; Male; Microdialysis; Motor Activity; Nicotine; Nucleus Accumbens; Phenols; Piperidines; Rats; Rats, Wistar; Receptors, N-Methyl-D-Aspartate | 2004 |
Involvement of the CA3-CA1 synapse in the acquisition of associative learning in behaving mice.
Topics: 2-Amino-5-phosphonovalerate; Acoustic Stimulation; Amnesia, Anterograde; Amnesia, Retrograde; Animals; Association Learning; Blinking; Conditioning, Classical; Electromyography; Electroshock; Excitatory Postsynaptic Potentials; Extinction, Psychological; Habituation, Psychophysiologic; Hippocampus; Learning Disabilities; Long-Term Potentiation; Male; Mental Recall; Mice; Mice, Inbred C57BL; Pyramidal Cells; Quinoxalines; Receptors, N-Methyl-D-Aspartate; Synapses; Trigeminal Nerve | 2006 |
Galantamine enhances dopaminergic neurotransmission in vivo via allosteric potentiation of nicotinic acetylcholine receptors.
Topics: 2-Amino-5-phosphonovalerate; Action Potentials; Analysis of Variance; Animals; Cholinesterase Inhibitors; Donepezil; Dopamine; Dose-Response Relationship, Drug; Excitatory Amino Acid Antagonists; Galantamine; Indans; Male; Mecamylamine; Microdialysis; Neurons; Nicotinic Antagonists; Piperidines; Prefrontal Cortex; Rats; Rats, Sprague-Dawley; Receptors, Nicotinic; Synaptic Transmission; Ventral Tegmental Area | 2007 |
An examination of NMDA receptor contribution to conditioned responding evoked by the conditional stimulus effects of nicotine.
Topics: 2-Amino-5-phosphonovalerate; Animals; Brain; Conditioning, Classical; Cyclopentanes; Discrimination, Psychological; Dizocilpine Maleate; Dose-Response Relationship, Drug; Drug Interactions; Excitatory Amino Acid Antagonists; Male; Mecamylamine; N-Methylaspartate; Nicotine; Phencyclidine; Phenols; Piperazines; Piperidines; Quinolones; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate | 2011 |
Orphenadrine-induced convulsive status epilepticus in rats responds to the NMDA antagonist dizocilpine.
Topics: 2-Amino-5-phosphonovalerate; Animals; Anticonvulsants; Dizocilpine Maleate; Electroencephalography; Hippocampus; Male; N-Methylaspartate; Orphenadrine; Rats; Rats, Wistar; Seizures; Status Epilepticus | 2014 |
Differential effects of early-life NMDA receptor antagonism on aspartame-impaired insulin tolerance and behavior.
Topics: 2-Amino-5-phosphonovalerate; Animals; Animals, Newborn; Aspartame; Behavior, Animal; Blood Glucose; Dark Adaptation; Excitatory Amino Acid Antagonists; Exploratory Behavior; Female; Insulin Resistance; Male; Mice; Mice, Inbred C57BL; Pregnancy; Prenatal Exposure Delayed Effects; Recognition, Psychology; Statistics, Nonparametric; Sweetening Agents | 2016 |
Effect of developmental NMDAR antagonism with CGP 39551 on aspartame-induced hypothalamic and adrenal gene expression.
Topics: 2-Amino-5-phosphonovalerate; Animals; Aspartame; Female; Gene Expression Regulation; Hypothalamo-Hypophyseal System; Male; Mice; Pituitary-Adrenal System; Receptors, N-Methyl-D-Aspartate | 2018 |